NEW

Healthmark Offers New Vendor Credentialing Program

Healthmark Industries’ clinical affairs team has announced the creation of 13 training programs that will be offered for vendors and manufacturer representatives to satisfy vendor credentialing requirements.

Interim Life in the Age of COVID

An interim director of surgical services is familiar with unpredictability. In a new assignment, the needs of the OR, often disparate, compete for their attention. Prioritizing what to execute first is a delicate balancing act.

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical Inc. (formerly TransEnterix Inc.) has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. A news release states that Asensus Surgical's technology...

Staying Positive During the Pandemic

The good news for patients in need of outpatient surgery is that, across the country, health care providers and policymakers have recognized that elective surgery is not the same thing as optional surgery and are allowing ASCs to remain open to provide this care.

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix

Aerobiotix Inc., a manufacturer of air treatment devices for hospitals and health care, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system. This system joins an expanding line of Aerobiotix technologies which utilize patented simultaneous mechanical and ultraviolet filtration to eliminate airborne contamination in clinical environments. Aerobiotix submitted independent data demonstrating effectiveness against viral and bacterial aerosols, as well as particulate contamination to support clearance.

The Aerocure-MD platform is unique in that it has FDA labeling to both destroy microorganisms in the air by exposure to ultraviolet radiation and also remove particles from the air via HEPA filtration. The system is designed for mobile, high-volume air decontamination applications in health care spaces such as acute care areas, contaminated storage and handling areas, and long-term health care facilities. Unlike other ultraviolet technologies, Aerobiotix uses a shielded internal ultraviolet system, preventing potentially hazardous exposure of personnel and material to ultraviolet rays.

“This clearance represents an important regulatory validation of our technology as we expand our footprint to cover all areas of health care. The growing challenge of airborne healthcare-acquired infections, including SARS-CoV-2, underscores the need for medical devices with rigorously investigated, peer-reviewed performance against airborne organisms in real-world clinical environments,” stated Dr. David Kirschman, MD, CEO of Aerobiotix, Inc.

Aerobiotix products, including the Illuvia nonturbulent air system for operating rooms, are used globally by leading medical centers and are supported by multiple published clinical studies.

For more information, visit www.aerobiotix.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X